Antidepressants can cause discontinuation symptoms when stopped or reduced, but they do not typically produce the intoxication, craving, and compulsive reward-seeking pattern associated with addiction.
AddictionInfo Editorial Team 7 minute read Evidence checked September 4, 2026
Clinical overview
Quick answer
Antidepressants can cause discontinuation symptoms when stopped or reduced, but they do not typically produce the intoxication, craving, and compulsive reward-seeking pattern associated with addiction.
Evidence checked4 September 2026
Editorial standardReviewed against current clinical and public-health guidance
ScopeEducation only—not diagnosis or individual medical advice
What this means
Discontinuation symptoms and return of the original condition can overlap. A planned reduction with follow-up helps distinguish them and protects mental health.
Key distinctions
Do not stop abruptly because of an online claim
urgent help is needed for suicidal intent, severe agitation, mania, or dangerous deterioration.
Signs and patterns clinicians assess
A clinician looks at the pattern over time, its severity, the person’s baseline, and the consequences—not at one isolated behaviour. Relevant features can include:
taking a medicine in a larger dose, more often, or for longer than directed
using someone else’s medication or using it for intoxication rather than the intended condition
seeking early refills, using several prescribers, concealment, or escalating use
difficulty reducing use because of withdrawal, rebound symptoms, craving, or fear
continued use despite sedation, falls, cognitive problems, mood change, or functional harm
These signs are not a self-diagnosis. Intoxication, withdrawal, prescribed use, pain, sleep disorders, and mental-health conditions can overlap, so assessment should establish what is happening and what is immediately unsafe.
Health and safety risks
Risk depends on the substance or medicine, route, dose, frequency, combinations, physical health, mental health, and environment. Important concerns include:
overdose or profound sedation, especially when depressant medicines are combined
seizure or severe withdrawal from abrupt cessation of some sedatives
falls, driving impairment, memory problems, and accidental injury
misunderstanding physical dependence as moral failure—or mistaking it for addiction without assessment
unmanaged pain, anxiety, insomnia, or ADHD when medication changes are not clinically coordinated
Assessment and treatment
Good care starts with consent, dignity, and a clear assessment of immediate risk. Treatment intensity should be matched to clinical need rather than to marketing labels or a fixed programme length.
a medication reconciliation covering prescriptions, over-the-counter products, alcohol, and other drugs
assessment of therapeutic benefit, harms, dependence, loss of control, and co-occurring conditions
an individual clinician-led taper when a gradual reduction is indicated
treatment of the original pain, sleep, anxiety, or attention problem using safer alternatives where possible
addiction treatment when compulsive use and significant harm meet criteria for a substance use disorder
Recovery plans should state who is responsible for medication, crisis support, physical-health follow-up, family communication, and continuing care. A lapse should trigger prompt reassessment and additional support—not abandonment or shame.
When to seek urgent help
Call emergency services for extreme sleepiness, slowed or stopped breathing, blue/grey lips, seizure, collapse, severe confusion, or suspected overdose. Do not abruptly stop benzodiazepines or other medicines associated with dangerous withdrawal without prescriber guidance.
Questions to ask a treatment provider
Who performs the medical and psychiatric assessment, and what are their current qualifications and registrations?
How is withdrawal, overdose, suicide risk, medication, and physical illness managed?
Which treatments are offered for this specific condition, and what evidence supports them?
What happens if symptoms worsen or hospital care is required?
How are outcomes, complaints, safeguarding, discharge, and continuing care handled?
Why antidepressant discontinuation is not usually addiction
Antidepressants can produce physical adaptation, so stopping suddenly or reducing too quickly may cause a discontinuation syndrome. This is different from addiction, which involves impaired control, compulsive use, craving for an intoxicating effect and continued use despite harm. Most people taking antidepressants do not experience euphoria or drug-seeking behaviour.
The distinction matters because withdrawal symptoms deserve careful treatment without stigmatising someone as addicted. It also prevents the opposite error: assuming that every problem after stopping is “all in the mind”.
Common discontinuation symptoms
Dizziness, imbalance or “electric shock” sensations
Flu-like feelings, sweating or headache
Nausea, diarrhoea or appetite change
Anxiety, irritability, tearfulness or agitation
Insomnia, vivid dreams or fatigue
Concentration difficulty and feelings of unreality
Symptoms vary by medicine, dose, duration, half-life and individual sensitivity. Some begin soon after a missed dose; others emerge later. A simple timetable cannot predict every course.
Discontinuation versus return of depression or anxiety
Withdrawal can begin relatively soon after a reduction and may include physical or sensory symptoms that were not part of the original condition. Relapse of depression or anxiety may develop more gradually and resemble the person’s previous illness. Both can occur together.
Response to reinstatement or dose adjustment can provide information, but decisions should be made with the prescriber. A detailed symptom timeline is more useful than assuming one explanation immediately.
Why abrupt stopping can be difficult
People may stop because they feel better, dislike side effects, become pregnant, lose access to a prescription or want to be medication-free. Sudden changes can produce distress that interferes with work, sleep and relationships. Severe symptoms can also be mistaken for a new psychiatric crisis.
Do not stop an antidepressant suddenly without discussing a plan, particularly after long-term use or previous difficult withdrawal. The prescriber can consider formulation, dose changes and monitoring.
No universal taper fits everyone
The appropriate reduction depends on the medicine, duration, dose, previous symptoms, mental health and preference. Some people tolerate a relatively straightforward taper; others need smaller changes and more time. Exact instructions should be individualised.
A plan should include what to do if symptoms emerge, how relapse will be monitored and who can be contacted between appointments. Using tablets inconsistently or alternating large doses can create fluctuating exposure.
Suicide risk and urgent symptoms
New or worsening suicidal thoughts, severe agitation, mania-like symptoms, psychosis or inability to stay safe requires urgent professional help. These symptoms can reflect relapse, withdrawal, a medication reaction or another condition. The cause can be clarified after immediate safety is addressed.
Family members should take marked behavioural change seriously and avoid leaving a person alone when there is immediate risk.
Antidepressants and substance use
Alcohol, cannabis, stimulants and sedatives can affect mood, sleep and the interpretation of discontinuation symptoms. A clinician should know the full pattern. Some substances can also increase impulsivity or interact with medication.
A person with addiction may still benefit from antidepressant treatment. Psychiatric care should be coordinated rather than withheld until perfect abstinence. See dual diagnosis.
What addiction to a medicine would look like
Addiction usually includes taking a substance for intoxication or relief in a way that becomes difficult to control, using more than intended, seeking several sources and continuing despite harm. Ordinary adherence to an antidepressant, concern about withdrawal or fear of relapse does not meet that pattern.
Language should remain precise. “Dependent” can also be misunderstood, so clinicians may explain that physiological adaptation is expected with some medicines and is not a moral or behavioural diagnosis.
Preparing to reduce
Choose a relatively stable period when possible. Review sleep, work, caregiving, physical health and access to therapy. Keep a record of dose changes and symptoms. Ensure that enough medication and the correct formulation are available so the plan is not forced by supply problems.
Do not crush, split or alter a formulation unless a pharmacist or prescriber confirms it is safe. Some modified-release products cannot be handled like ordinary tablets.
Treating the original condition
Psychological therapy, exercise, sleep treatment, social support and condition-specific care can reduce relapse risk. These supports should be in place before the medicine is fully withdrawn when possible. The aim is not to prove independence from medication, but to maintain health and function.
Some people decide that continuing medication remains the best option. Long-term use can be appropriate when benefit outweighs harm and regular review occurs.
When a higher level of care is needed
Most discontinuation can be managed in outpatient care. Hospital or crisis support may be required for severe suicidality, mania, psychosis, inability to eat or drink, or major functional collapse. A residential or luxury rehab is not automatically appropriate for antidepressant withdrawal and should not market ordinary discontinuation as addiction.
If residential care is considered because of co-occurring addiction or severe mental illness, verify psychiatric prescribing, emergency pathways and continuity after discharge.
Recovery and follow-up
Symptoms often improve, but the course can be uneven. Regular review helps distinguish withdrawal from relapse and avoids repeated abrupt changes. The person should have a route back to treatment if the original condition returns.
Yes. Treatment should be matched to the substance or behaviour, severity, withdrawal and overdose risk, physical and mental health, previous response, goals, and available support. More than one episode of care may be needed.
Does withdrawal mean someone has an addiction?
Not necessarily. Withdrawal can indicate physical dependence, including during appropriate prescribed treatment. Addiction additionally involves impaired control, prioritisation, and continued use despite harm. A clinician can distinguish these patterns.
What is the safest first step?
Arrange a confidential assessment with a qualified addiction or medical service. Use emergency services immediately for overdose, seizure, breathing difficulty, severe confusion, dangerous psychosis, or immediate suicide risk.
Sources and clinical guidance
Sources are selected for clinical authority and public accessibility. Publication does not imply endorsement of any treatment provider.
Yes. Treatment should be matched to the substance or behaviour, severity, withdrawal and overdose risk, physical and mental health, previous response, goals, and available support.
Does withdrawal always mean someone has an addiction?
No. Withdrawal can indicate physical dependence, including during appropriate prescribed treatment. Addiction additionally involves impaired control, prioritisation, and continued use despite harm.
What is the safest first step?
Arrange a confidential assessment with a qualified addiction or medical service. Use emergency services immediately for overdose, seizure, breathing difficulty, severe confusion, dangerous psychosis, or immediate suicide risk.
Prepared by the AddictionInfo Editorial Team and last evidence-checked on September 4, 2026. We distinguish education from medical advice, link material claims to primary or authoritative sources, and correct substantive errors transparently. Read our editorial standards.
Prescription drug addiction can involve opioids, benzodiazepines, stimulants, sedatives, or other medicines. The key issue is not whether a drug was prescribed,…
Pregabalin and gabapentin are prescribed for selected conditions but can be misused and may cause dependence or withdrawal. Sedation and overdose risk…